BLUEBIRD BIO INC (BLUE)
US09609G1004 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 165.30M | 113.00M | 161.20M | 317.70M | 327.20M | |||
| Marketable Securities | 8.90M | 67.30M | 138.30M | 833.50M | 779.20M | |||
| Receivables | 23.00M | N/A | N/A | 400.00K | 400.00K | |||
| Inventories | 21.00M | N/A | 0.00 | N/A | N/A | |||
| Other Current Assets | 28.80M | 19.20M | 37.00M | 63.90M | 45.30M | |||
| Total Current Assets | 247.10M | 199.50M | 336.50M | 1.22B | 1.15B | |||
| Non-Current Assets | ||||||||
| PPE Net | 304.70M | 291.40M | 101.20M | 346.90M | 337.10M | |||
| Investments And Advances | 0.00 | 1.40M | 97.10M | 122.90M | 131.50M | |||
| Goodwill | 5.60M | 5.60M | 5.60M | 13.10M | 13.10M | |||
| Intangibles | 5.40M | 4.90M | 0.00 | 10.00M | 14.30M | |||
| Other Non-Current Assets | 50.80M | 52.10M | 53.30M | 72.80M | 79.20M | |||
| Total Non-Current Assets | 366.50M | 355.40M | 257.30M | 565.80M | 575.20M | |||
| TOTAL ASSETS | 613.60M | 554.90M | 593.80M | 1.78B | 1.73B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 121.50M | 100.90M | 123.70M | 149.80M | 136.40M | |||
| Accounts Payable | 19.90M | 25.10M | 25.90M | 21.60M | 43.00M | |||
| Other Current Liabilities | 17.70M | 2.30M | 3.40M | 32.20M | 44.20M | |||
| Total Current Liabilities | 159.00M | 128.20M | 153.00M | 203.60M | 223.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 232.10M | 230.30M | 66.50M | 222.60M | 218.90M | |||
| Total Non-Current Liabilities | 232.10M | 230.40M | 66.50M | 222.60M | 218.80M | |||
| TOTAL LIABILITIES | 391.10M | 358.60M | 219.50M | 426.20M | 442.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -4.11B | -3.99B | -3.72B | -2.90B | -2.28B | |||
| Additional Paid In Capital | 4.33B | 4.19B | 4.10B | 4.26B | 3.57B | |||
| Common Shares | 1.10M | 800.00K | 700.00K | 700.00K | 600.00K | |||
| Other Shareholders' Equity | -2.20M | -4.10M | -2.90M | -5.50M | -1.90M | |||
| Shares Outstanding | 107.00M | 82.90M | 71.10M | 66.40M | 55.40M | |||
| Tangible Book Value per Share | 1.98 | 2.24 | 5.19 | 20.06 | 22.70 | |||
| Total Shareholders' Equity | 222.50M | 196.30M | 374.30M | 1.36B | 1.28B | |||
| TOTAL LIABILITIES AND EQUITY | 613.60M | 554.90M | 593.80M | 1.78B | 1.73B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.55 | 1.56 | 2.20 | 5.97 | 5.15 | |||
| Return On Assets (ROA) | -14.86% | -48.04% | -137.99% | -34.73% | -45.71% | |||
| Return On Equity (ROE) | -40.99% | -135.80% | -218.91% | -45.66% | -61.45% | |||
All data in USD